FeesSafety
Pluang+

Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Company Fundamentals
02 Nov 2026, 19:00 WIB
Na
View Source
Neutral
Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from Heineken Holding N.V. between October 26 and 30. This ongoing buyback aims to return value to shareholders and optimize capital structure. Heineken provides weekly updates on the program's progress on its website.

Heineken N.V.'s share buyback program has repurchased 9,510,681 shares, spending €679.2 million as of October 30, 2026. For readers following Consumer Staples, here is Pluang's market snapshot as of Nov 02, 2026 19:12 WIB: out of 63 priced US stocks, 30 rose and 19 fell today. Notable movers include BF.B at USD 29.14 (+1.50%), BYND at USD 7.00 (+1.30%), and DG at USD 131.13 (-0.88%).

More News

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...

Market News
Bearish
12 minutes ago
Alvotech to present at multiple investor conferences in November 2026.

Alvotech to present at multiple investor conferences in November 2026.

Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...

Market News
Neutral
12 minutes ago
Alvotech to present at multiple investor conferences in November 2026

Alvotech to present at multiple investor conferences in November 2026

Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...

Market News
Neutral
12 minutes ago
Alvotech to present at four major investor conferences in November across Europe.

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
Neutral
12 minutes ago
Research reveals financial abuse is a common but under-recognized form of domestic abuse in Canada.

Research reveals financial abuse is a common but under-recognized form of domestic abuse in Canada.

New research by The Allstate Foundation of Canada shows that while 75% of Canadians have experienced or know someone who has experienced domestic abuse, only 9% recognize financial abuse as a form of it. However, 56% of abuse survivors identified fin...

Others
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App